Cargando…

Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol

Neurodevelopmental disorders are a heterogeneous group of conditions with overlapping symptomatology and fluctuating developmental trajectories that transcend current diagnostic categorisation. There is a need for validated screening instruments which dimensionally assess symptomatology from a holis...

Descripción completa

Detalles Bibliográficos
Autores principales: Masi, Anne, Azim, Syeda Ishra, Lam-Cassettari, Christa, Dadds, Mark, Mendoza Diaz, Antonio, Henry, Georgina, Karlov, Lisa, Lin, Ping-I, Mallitt, Kylie-Ann, Montgomery, Alicia, Strnadová, Iva, Whitehouse, Andrew, Eapen, Valsamma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657806/
https://www.ncbi.nlm.nih.gov/pubmed/34886563
http://dx.doi.org/10.3390/ijerph182312837
_version_ 1784612586907500544
author Masi, Anne
Azim, Syeda Ishra
Lam-Cassettari, Christa
Dadds, Mark
Mendoza Diaz, Antonio
Henry, Georgina
Karlov, Lisa
Lin, Ping-I
Mallitt, Kylie-Ann
Montgomery, Alicia
Strnadová, Iva
Whitehouse, Andrew
Eapen, Valsamma
author_facet Masi, Anne
Azim, Syeda Ishra
Lam-Cassettari, Christa
Dadds, Mark
Mendoza Diaz, Antonio
Henry, Georgina
Karlov, Lisa
Lin, Ping-I
Mallitt, Kylie-Ann
Montgomery, Alicia
Strnadová, Iva
Whitehouse, Andrew
Eapen, Valsamma
author_sort Masi, Anne
collection PubMed
description Neurodevelopmental disorders are a heterogeneous group of conditions with overlapping symptomatology and fluctuating developmental trajectories that transcend current diagnostic categorisation. There is a need for validated screening instruments which dimensionally assess symptomatology from a holistic, transdiagnostic perspective. The primary aim is to co-design a Neurodevelopment Assessment Scale (NAS), a user-friendly transdiagnostic assessment inventory that systematically screens for all signs and symptoms commonly encountered in neurodevelopmental disorders. Our first objective is to undertake development of this tool, utilising co-design principles in partnership with stakeholders, including both those with lived experience of neurodevelopmental disorders and service providers. Our second objective is to evaluate the face validity, as well as the perceived utility, user-friendliness, suitability, and acceptability (i.e., ‘social validity’), of the NAS from the perspective of parents/caregivers and adults with neurodevelopmental disorders, clinicians, and service providers. Our third objective is to ascertain the psychometric properties of the NAS, including content validity and convergent validity. The NAS will provide an efficient transdiagnostic tool for evaluating all relevant signs, symptoms, and the dimensional constructs that underpin neurodevelopmental presentations. It is anticipated that this will maximise outcomes by enabling the delivery of personalised care tailored to an individual’s unique profile in a holistic and efficient manner.
format Online
Article
Text
id pubmed-8657806
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86578062021-12-10 Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol Masi, Anne Azim, Syeda Ishra Lam-Cassettari, Christa Dadds, Mark Mendoza Diaz, Antonio Henry, Georgina Karlov, Lisa Lin, Ping-I Mallitt, Kylie-Ann Montgomery, Alicia Strnadová, Iva Whitehouse, Andrew Eapen, Valsamma Int J Environ Res Public Health Article Neurodevelopmental disorders are a heterogeneous group of conditions with overlapping symptomatology and fluctuating developmental trajectories that transcend current diagnostic categorisation. There is a need for validated screening instruments which dimensionally assess symptomatology from a holistic, transdiagnostic perspective. The primary aim is to co-design a Neurodevelopment Assessment Scale (NAS), a user-friendly transdiagnostic assessment inventory that systematically screens for all signs and symptoms commonly encountered in neurodevelopmental disorders. Our first objective is to undertake development of this tool, utilising co-design principles in partnership with stakeholders, including both those with lived experience of neurodevelopmental disorders and service providers. Our second objective is to evaluate the face validity, as well as the perceived utility, user-friendliness, suitability, and acceptability (i.e., ‘social validity’), of the NAS from the perspective of parents/caregivers and adults with neurodevelopmental disorders, clinicians, and service providers. Our third objective is to ascertain the psychometric properties of the NAS, including content validity and convergent validity. The NAS will provide an efficient transdiagnostic tool for evaluating all relevant signs, symptoms, and the dimensional constructs that underpin neurodevelopmental presentations. It is anticipated that this will maximise outcomes by enabling the delivery of personalised care tailored to an individual’s unique profile in a holistic and efficient manner. MDPI 2021-12-06 /pmc/articles/PMC8657806/ /pubmed/34886563 http://dx.doi.org/10.3390/ijerph182312837 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Masi, Anne
Azim, Syeda Ishra
Lam-Cassettari, Christa
Dadds, Mark
Mendoza Diaz, Antonio
Henry, Georgina
Karlov, Lisa
Lin, Ping-I
Mallitt, Kylie-Ann
Montgomery, Alicia
Strnadová, Iva
Whitehouse, Andrew
Eapen, Valsamma
Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol
title Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol
title_full Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol
title_fullStr Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol
title_full_unstemmed Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol
title_short Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol
title_sort co-design of a neurodevelopment assessment scale: a study protocol
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657806/
https://www.ncbi.nlm.nih.gov/pubmed/34886563
http://dx.doi.org/10.3390/ijerph182312837
work_keys_str_mv AT masianne codesignofaneurodevelopmentassessmentscaleastudyprotocol
AT azimsyedaishra codesignofaneurodevelopmentassessmentscaleastudyprotocol
AT lamcassettarichrista codesignofaneurodevelopmentassessmentscaleastudyprotocol
AT daddsmark codesignofaneurodevelopmentassessmentscaleastudyprotocol
AT mendozadiazantonio codesignofaneurodevelopmentassessmentscaleastudyprotocol
AT henrygeorgina codesignofaneurodevelopmentassessmentscaleastudyprotocol
AT karlovlisa codesignofaneurodevelopmentassessmentscaleastudyprotocol
AT linpingi codesignofaneurodevelopmentassessmentscaleastudyprotocol
AT mallittkylieann codesignofaneurodevelopmentassessmentscaleastudyprotocol
AT montgomeryalicia codesignofaneurodevelopmentassessmentscaleastudyprotocol
AT strnadovaiva codesignofaneurodevelopmentassessmentscaleastudyprotocol
AT whitehouseandrew codesignofaneurodevelopmentassessmentscaleastudyprotocol
AT eapenvalsamma codesignofaneurodevelopmentassessmentscaleastudyprotocol